Clinical Trial Update: Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan [Phase 2]

View source ↗

Summary

This clinical trial update concerns a Phase 2 study evaluating fexinidazole for visceral leishmaniasis in Sudan. The study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visceral Leishmaniasis

Drugs mentioned

• Fexinidazole (fexinidazole)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Visceral Leishmaniasis | Phase 2 | Status: TERMINATED